NP
Insider
Naimish Patel
Chief Medical OfficerNaimish Patel (Chief Medical Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in CRISPR Therapeutics AG (CRSP). The largest single filing was $211K of CRSP (3,786 sh × $55.62, as filed), executed May 29.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$363K
shares × price, as filed
Last traded
May 29
Filed Jun 1
Median ADV $94.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $504K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
CRSPRecent filings
CRSPSALE
CRISPR Therapeutics AG
View filing →
$211K3,786 sh × $55.62
Exec May 29
Filed Jun 1 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $152K
3,150 sh × $48.26
Exec Mar 16
Filed Mar 17 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $141K
3,932 sh × $35.94
Exec May 29 2025
Filed May 30 2025 · 5:30 PM ET